收藏切换
Quality status and countermeasures of randomized controlled trials of traditional Chinese medicine in treatment of children with adenoid hypertrophy
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(9) : 3234 - 3244
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(9): 3234-3244
Quality status and countermeasures of randomized controlled trials of traditional Chinese medicine in treatment of children with adenoid hypertrophy
Full
LIU Ping1, CAI Qiuhan1, CHEN Yueyue1, CHENG Shanshan1, XU Yaqian1, HU Siyuan1
Affiliations
    1 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China
doi: 10.7501/j.issn.0253-2670.2025.09.020
Outline
收藏切换
Objective To evaluate the methodological and reporting quality of randomized controlled trials (RCTs) of traditional Chinese medicine (TCM) for the treatment of adenoid hypertrophy (AH) in children and analyze the current status of clinical trial design, in order to provide a reference for future RCTs of AH in children. Methods CNKI, Wanfang, VIP, SinoMed, PubMed, Cochrane Library, Embase, Web of Science, ClinicalTrials.gov, Chinese Clinical Trial Registry, and International Traditional Medicine Clinical Trial Registry were systematically searched for RCTs on TCM in the treatment of AH in children, with the time interval from database inception to May 15, 2024, RCTs were included according to the inclusion and exclusion criteria. The ROB 2.0 tool and the CONSORT-Outcomes 2022 extension were used to evaluate the methodological and reporting quality of the literature, respectively. The basic characteristics of clinical trial designs were summarized, with a focus on the analysis of outcome measures Results A total of 182 RCTs were included, including 178 articles and four registration information; the sample size was 14798 cases, concentrated in 60—100 cases (84.07%); the intervention measures were mainly Chinese herbal medicine (86.29%), and the control measures were mainly chemical drugs (74.73%); the treatment course was concentrated in 4—12 weeks (86.26%). The results of ROB 2.0 showed that the overall risk of bias of the literature was “some concerns” in 166 articles (93.3%) and “high risk of bias” in 12 articles (6.74%). The results of CONSORT-Outcomes 2022 Extension showed that the reporting rate of 41 items (75.93%) was less than 50%. A total of 90 outcome indicators were reported, with a frequency of 996 times, which were divided into eight indicator domains: nine TCM disease and syndrome indicators with a frequency of 264 times (26.51%), 50 physical and chemical examination indicators with a frequency of 256 times (25.70%), 13 symptom/sign indicators with a frequency of 244 times (24.50%), 8 safety event indicators with a frequency of 101 times (10.14%), six quality of life indicators with a frequency of 97 times (9.74%), two long-term prognosis indicators with a frequency of 32 times (3.21%), two other indicators with a frequency of 2 times (0.20%), and 0 economic evaluation indicators. Conclusion The overall quality of RCTs for TCM treatment of AH in children is poor, and there are many problems in the design of clinical trials. Future studies should prioritize rigorously designed trials that reflect TCM's clinical advantages to promote the transformation of clinical research into clinical application.
traditional Chinese medicine  /  children  /  adenoid hypertrophy  /  randomized controlled trial  /  quality evaluation  /  outcome indicators
柳平, 蔡秋晗, 陈月月, 程珊珊, 许雅倩, 胡思源. 中医药治疗儿童腺样体肥大随机对照试验的质量现状及应对策略. 中草药, 2025 , 56 (9) : 3234 -3244 . DOI: 10.7501/j.issn.0253-2670.2025.09.020
LIU Ping, CAI Qiuhan, CHEN Yueyue, CHENG Shanshan, XU Yaqian, HU Siyuan. Quality status and countermeasures of randomized controlled trials of traditional Chinese medicine in treatment of children with adenoid hypertrophy[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (9) : 3234 -3244 . DOI: 10.7501/j.issn.0253-2670.2025.09.020
Year 2025 volume 56 Issue 9
52
11
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.09.020
  • Receive Date:2025-02-11
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2025-02-11
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.09.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT